Risk Management

Fluorescein Angiography: Preventing and Responding to Complications

Fluorescein angiography (FA) is a diagnostic procedure. A photographer takes a rapid sequence of photographs of the blood vessels in the retina and choroid (the back of the eye). The dye is usually injected into a vein in the arm, forearm, or hand. While generally well tolerated, angiography is an invasive procedure with risks. The most severe risk, while rare, is of a life-threatening allergic reaction. Here are some risk management recommendations to help you and your staff members prevent and better respond to the risks of the procedure. Issues addressed in Fluorescein Angiography Recommendations and Consent include delegation of tasks, informed consent, emergency response equipment, and management of complications.

See this document by using the download button above.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.